bendamustine hydrochloride has been researched along with uric acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adam, K; Bergmann, J; Buchheidt, D; Hehlmann, R; Hummel, M; Reiter, S | 1 |
Beijnen, JH; Darwish, M; Dubbelman, AC; Hellriegel, E; Jansen, RS; Robertson, P; Rosing, H; Schellens, JH | 1 |
2 other study(ies) available for bendamustine hydrochloride and uric acid
Article | Year |
---|---|
Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Creatinine; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Recombinant Proteins; Renal Insufficiency; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid; Vidarabine | 2005 |
Metabolite profiling of bendamustine in urine of cancer patients after administration of [14C]bendamustine.
Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Carbon Radioisotopes; Creatinine; Cysteine; Dealkylation; Humans; Hydrolysis; Hydroxylation; Metabolic Networks and Pathways; Metabolome; Neoplasms; Nitrogen Mustard Compounds; Oxidation-Reduction; Phosphates; Uric Acid | 2012 |